Epynext Therapeutics

Sepsis can arise from everyday infections like those in the lungs, urinary tract, gut, and skin. As antimicrobial resistance (AMR) grows, treating these infections becomes more challenging, putting more people at risk of severe complications. Join our mission, stay informed, and help raise awareness. 🔷 #AMResistanceFighters #StopSepsis #SaveLives

Antimicrobial resistance (AMR) is accelerating, putting a century of medical progress at risk. We have the science at our fingertips that can solve this looming crisis – but companies that devote resources to this fundamental field currently face untenable levels of risk, with recent billion-dollar investments incurring huge financial losses. In this month’s #120months article, I address how governments and health bodies across the world must tackle the looming threat of AMR: in addition to curbing mis- and over-use of antibiotics, they must create market conditions that drive the innovation needed for the survival of medicine as we know it.

[#LBPevent] Découvrez les premiers pitchs sélectionnés du Bluesky Meeting de la 18ème Journée Collaborative ! 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬 𝐢𝐧𝐧𝐨𝐯𝐚𝐧𝐭𝐞𝐬 𝐨𝐮 𝐫𝐞𝐜𝐡𝐞𝐫𝐜𝐡𝐞𝐬 𝐝𝐞 𝐩𝐚𝐫𝐭𝐞𝐧𝐚𝐢𝐫𝐞𝐬 𝐞𝐧 𝐯𝐮𝐞 𝐝𝐞 𝐩𝐫𝐨𝐣𝐞𝐭𝐬 𝐑&𝐃 : 🔹PEPR Exploratoire « organes & organoïdes-sur-puce » (MED-OOC), CEA par Fabrice Navarro 🔹Consortium d'Accélération et de Transfert pour la Réponse aux Infections Emergeantes et aux Menaces (CATRIEM), PULSALYS par Catherine DAUMAS 🔹Epymics, an AI drug discovery platform to tackle Antimicrobial Resistance, Epynext Therapeutics par Louis Farge 🔹AI powered, nature inspired, computer-driven drug design, Meddenovo Drug Design par Antoine MARION 🔹New chemical Entities to stop anticancer drugs efflux and enhance treatment effectiveness, ReACT Therapeutics par Lise Clément-Demange 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧𝐬 𝐜𝐥𝐢𝐧𝐢𝐪𝐮𝐞𝐬 : 🔹Julien Jung Médecin Chercheur, Hospices Civils de Lyon - HCL, Service de neurologie fonctionnelle et épileptologie 🔹Saintigny Pierre, PUPH, Centre Léon Bérard 🔹Tobias Gauss, CHU Grenoble Alpes, Pôle Anesthésie-Réanimation 🔹Gaëtan De Luca, Infirmier en équipe mobile de crise, Le Vinatier - Psychiatrie Universitaire Lyon Métropole La 1ère vague de candidature est clôturée. Vous pouvez candidater à la 2ème vague jusqu'au 13 septembre avant 12h ! ➡ https://lnkd.in/dfawyV3y 📅 15 octobre 2024 📍 Hôtel de Région de Lyon ➡ https://lnkd.in/dfysMemP

Work in progress, stay tuned! #AMR #antibioresistance #AI #IA #DeepTech #Innovation #France2030 #Biotech #Grenoble https://lnkd.in/eTtzwdKs

A strain of hypervirulent, carbapenem-resistant Klebsiella pneumoniae is being traced across Europe. As noted by Center for Infectious Disease Research and Policy (CIDRAP), the combination of hypervirulence with resistance to last-resort antibiotics is leading to “potentially untreatable infections.” https://lnkd.in/gGGDwMut

Un appel à relayer! Heureusement un vaccin existe alors que "l'on observe une augmentation progressive de la résistance des méningocoques aux antibiotiques (augmentation de la proportion de souches de sensibilité diminuée à la pénicilline). La létalité de ces infections est de 10 à 12%, et des séquelles invalidantes sont observées chez plus de 10 % des survivants." (in https://lnkd.in/eMWK-Ha6). #AMR #antibioresistance Epynext Therapeutics https://lnkd.in/eB2EDAfM

"AMR has been directly responsible for 1,5 million deaths worldwide in 2019, more than HIV or malaria. If nothing is done now, AMR deaths will top those due to cancer or atherosclerosis by 2050 and be again, like in the early 20th century, the first cause of death worlwide." https://lnkd.in/e8gY9-EA

While oncology care has been making significant strides, the same can’t be said for infection control. That’s why the Cancer & AMR Consortium was created—to understand the link between cancer and superbugs, and be a voice for change. Learn more here: https://lnkd.in/eUU_VNBT #WorldCancerDay #AMR #UICC

Antimicrobial resistance won’t hit us hard and fast like a pandemic, instead we will see a steady rise in cases of infections becoming once again untreatable. Often underestimated, the impact of drug-resistance extends beyond healthcare, affecting economies and societal stability. At GARDP, we're addressing this challenge head-on by developing new treatments and advocating for comprehensive global action against AMR. Understanding the scope of this issue is crucial. For a deeper insight into why drug resistance is one of our biggest global health security blind spots, check out the recent article by Dr Manica Balasegaram for World Economic Forum: https://lnkd.in/dN42QmJB #AMR #GlobalHealth #globalhealthsecurity #antibioticresistance

Rendez-vous Jeudi et Vendredi cette semaine!